Deal-Ticker: Rakuten Medical acquires Ecublens-based Medlight SA

Medlight produces and commercializes a large range of optical fiber based catheters for accurate illumination of tissue, used in new tumor treatments based on light energy.

Rakuten Medical, Inc. is a global biotechnology company developing precision, cell-targeting investigational therapies on its IlluminoxTM platform, which, in preclinical studies, have shown to lead to rapid and selective cell killing and tumor necrosis.

The terms of the transaction are confidential.

The Kellerhals Carrard team was composed of Frédéric Rochat, Elena Burger and Shima Gennari.

For further details on the transaction, please see the press-release